Manuscripts and Publications
Filters: Author is Siegler, Aaron J [Clear All Filters]
Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions.. AIDS Behav. 24(9):2637-2649.
.
2020. Siegler et al. Respond.. Am J Public Health. 110(1):e3-e4.
.
2020. PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.. AIDS Care. 33(6):706-711.
.
2021. Preexposure Prophylaxis Indication Criteria Underidentify Black and Latinx Persons and Require Revision.. Am J Public Health. 110(3):267-268.
.
2020. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.. Ann Epidemiol. 45:24-31.e3.
.
2020. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.. J Int AIDS Soc. 22(2):e25252.
.
2019. Needed: A Life Course Perspective on Maintaining Pre-exposure Prophylaxis Use.. Clin Infect Dis. 72(3):386-387.
.
2021. .
2021. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.. Ann Epidemiol. 44:16-30.
.
2020. Law Everywhere: A Causal Framework for Law and Infectious Disease.. Public Health Rep. 135(1_suppl):25S-31S.
.
2020. Implementation Strategies to Increase PrEP Uptake in the South.. Curr HIV/AIDS Rep. 16(4):259-269.
.
2019. .
2019. .
2019.